Home/Filings/4/0001213900-24-084758
4//SEC Filing

Pierce Kristen 4

Accession 0001213900-24-084758

CIK 0001870404other

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 7:02 PM ET

Size

5.7 KB

Accession

0001213900-24-084758

Insider Transaction Report

Form 4
Period: 2024-10-01
Pierce Kristen
Chief Development Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-10-01+200,000200,000 total
    Exercise: $0.10Exp: 2034-09-30Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]The shares underlying this option vest in twenty-four (24) monthly installments following the grant date, subject to the Reporting Person's continued service on each such vesting date.

Documents

1 file

Issuer

CERO THERAPEUTICS HOLDINGS, INC.

CIK 0001870404

Entity typeother

Related Parties

1
  • filerCIK 0002039649

Filing Metadata

Form type
4
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 7:02 PM ET
Size
5.7 KB